Skip to content
OpenCapital
Get started

Agilon Health AGL Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

Elevance Health logo
Elevance HealthELV
$305M+142%
National Healthcare logo
National HealthcareNHC
——

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%—

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's equity in earnings (losses) of equity method investees?
Agilon Health (AGL) reported equity in earnings (losses) of equity method investees of $11.73M in Q1 2026.
How has Agilon Health's equity in earnings (losses) of equity method investees changed year-over-year?
Agilon Health's equity in earnings (losses) of equity method investees decreased by 7.4% year-over-year, from $12.67M to $11.73M.
What is the long-term trend for Agilon Health's equity in earnings (losses) of equity method investees?
Over 2 years (2021 to 2025), Agilon Health's equity in earnings (losses) of equity method investees has grown at a -47.9% compound annual growth rate (CAGR), from -$6.77M to -$1.84M.